Multi-center Cross-sectional Epidemiological Study to Characterize the Prevalence and Distribution of Lipoprotein(a) Levels Among Patients With Established Cardiovascular Disease

CompletadoClinicalTrials.gov

ID: NCT03887520Tipo: INTERVENTIONALInicio: 27 de nov de 2018Fin estimado: 30 de jul de 2021

Traducción no disponible, mostrando original

Resumen

The study is conducted to improve knowledge about the epidemiology of Lipoprotein(a) in patients with established cardiovascular disease (CVD).

Elegibilidad

Edad mínima: 18 YearsEdad máxima: 80 YearsSexo: ALL

Criterios de inclusión

Signed informed consent
Established CVD defined as one of the following:
History of a myocardial infarction (MI) ≥3 months and ≤10 years before the study visit
History of ischemic stroke ≥ 3 months and ≤ 10 years before the study visit
Symptomatic PAD (intermitted claudication with ankle-brachial index ≤0.90 and/or lower limb amputation or re-vascularization due to lower limb ischemia

Criterios de exclusión

\- Patients currently enrolled in clinical studies with investigational drugs

Intervenciones

diagnostic_test

Blood draw for Lp(a)

Collect sample for Lipoprotein(a) testing

Ubicaciones

Novartis Investigative Site

CABA, Buenos Aires, Argentina

Novartis Investigative Site

CABA, Buenos Aires, Argentina

Novartis Investigative Site

Caba, Buenos Aires, Argentina

Novartis Investigative Site

Mar del Plata, Buenos Aires, Argentina

Novartis Investigative Site

Ramos Mejía, Buenos Aires, Argentina

Novartis Investigative Site

San Miguel de Tucumán, San Miguel de Tucuman, Argentina

Novartis Investigative Site

Rosario, Santa Fe Province, Argentina

Novartis Investigative Site

Rosario, Santa Fe Province, Argentina

Novartis Investigative Site

San Miguel de Tucumán, Tucumán Province, Argentina

Novartis Investigative Site

Buenos Aires, Argentina

Novartis Investigative Site

CABA, Argentina

Novartis Investigative Site

Caba, Argentina

Novartis Investigative Site

Corrientes, Argentina

Novartis Investigative Site

Córdoba, Argentina

Novartis Investigative Site

Córdoba, Argentina

Novartis Investigative Site

Formosa, Argentina

Novartis Investigative Site

San Luis, Argentina

Novartis Investigative Site

Santa Fe, Argentina

Patrocinadores

PrincipalNovartis Pharmaceuticals

Aviso: La información de este ensayo proviene de fuentes públicas y tiene carácter exclusivamente informativo. No constituye asesoramiento médico, regulatorio ni de ningún otro tipo. Las traducciones son automatizadas y no poseen validez oficial. Consultá siempre con un profesional de la salud. Ver Términos de Uso.

Multi-center Cross-sectional Epidemiological Study to Cha... | EligiMed